ArticleTherapeutic advances in medical oncology2022

Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors.

Ting Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.